Tanshinone IIA-Loaded Nanoparticle and Neural Stem Cell Therapy Enhances Recovery in a Pig Ischemic Stroke Model.
Erin E KaiserElizabeth S WatersXueyuan YangMadison M FaganKelly M ScheulinSydney E SneedSavannah R CheekJulie Heejin JeonSoo K ShinHolly A KinderAnil KumarSimon R PlattKylee J DubersteinHea Jin ParkJin XieFranklin D WestPublished in: Stem cells translational medicine (2022)
Induced pluripotent stem cell-derived neural stem cells (iNSCs) are a multimodal stroke therapeutic that possess neuroprotective, regenerative, and cell replacement capabilities post-ischemia. However, long-term engraftment and efficacy of iNSCs is limited by the cytotoxic microenvironment post-stroke. Tanshinone IIA (Tan IIA) is a therapeutic that demonstrates anti-inflammatory and antioxidative effects in rodent ischemic stroke models and stroke patients. Therefore, pretreatment with Tan IIA may create a microenvironment that is more conducive to the long-term survival of iNSCs. In this study, we evaluated the potential of Tan IIA drug-loaded nanoparticles (Tan IIA-NPs) to improve iNSC engraftment and efficacy, thus potentially leading to enhanced cellular, tissue, and functional recovery in a translational pig ischemic stroke model. Twenty-two pigs underwent middle cerebral artery occlusion (MCAO) and were randomly assigned to a PBS + PBS, PBS + iNSC, or Tan IIA-NP + iNSC treatment group. Magnetic resonance imaging (MRI), modified Rankin Scale neurological evaluation, and immunohistochemistry were performed over a 12-week study period. Immunohistochemistry indicated pretreatment with Tan IIA-NPs increased iNSC survivability. Furthermore, Tan IIA-NPs increased iNSC neuronal differentiation and decreased iNSC reactive astrocyte differentiation. Tan IIA-NP + iNSC treatment enhanced endogenous neuroprotective and regenerative activities by decreasing the intracerebral cellular immune response, preserving endogenous neurons, and increasing neuroblast formation. MRI assessments revealed Tan IIA-NP + iNSC treatment reduced lesion volumes and midline shift. Tissue preservation and recovery corresponded with significant improvements in neurological recovery. This study demonstrated pretreatment with Tan IIA-NPs increased iNSC engraftment, enhanced cellular and tissue recovery, and improved neurological function in a translational pig stroke model.
Keyphrases
- cell therapy
- magnetic resonance imaging
- stem cells
- atrial fibrillation
- immune response
- mesenchymal stem cells
- cerebral ischemia
- middle cerebral artery
- contrast enhanced
- anti inflammatory
- drug delivery
- single cell
- emergency department
- chronic pain
- bone marrow
- oxide nanoparticles
- inflammatory response
- oxidative stress
- spinal cord injury
- combination therapy
- stress induced
- drug induced
- pain management
- diabetic rats
- hematopoietic stem cell
- clinical evaluation